Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 266,201 |
|
|||||
| News | - | ||||||
| Day High | 0.555064 | Low High |
|||||
| Day Low | 0.52 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Brainstorm Cell Therapeutics Inc | BCLI | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0232 | 4.36% | 0.5552 | 23:00:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.547 | 0.52 | 0.555064 | 0.5345 | 0.532 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 849 | 266,201 | US$ 0.5335732 | US$ 142,038 | - | 0.134 - 3.34 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:58:23 | formt | 1,000 | US$ 0.5552 | USD |
Brainstorm Cell Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 48.98M | - | 0 | -17.19M | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Brainstorm Cell Therapeu... News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCLI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.50 | 0.61 | 0.4523 | 0.5341936 | 403,309 | 0.0552 | 11.04% |
| 1 Month | 0.6085 | 0.75 | 0.45 | 0.6173811 | 1,013,068 | -0.0533 | -8.76% |
| 3 Months | 0.385 | 0.792699 | 0.27 | 0.5058617 | 992,963 | 0.1702 | 44.21% |
| 6 Months | 0.1534 | 0.792699 | 0.134 | 0.3217586 | 1,804,960 | 0.4018 | 261.93% |
| 1 Year | 2.79 | 3.34 | 0.134 | 0.414584 | 1,403,646 | -2.23 | -80.10% |
| 3 Years | 3.53 | 4.70 | 0.134 | 1.12 | 629,967 | -2.97 | -84.27% |
| 5 Years | 4.05 | 17.95 | 0.134 | 3.43 | 617,655 | -3.49 | -86.29% |
Brainstorm Cell Therapeu... Description
| Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases. |
